Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Achilles Therapeutics (ACHL)
NASDAQ:ACHL
RESEARCH TOOLSreports
Holding ACHL?
Track your performance easily
ACHL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.63 - $1.76
Previous Close$1.07
Volume96.52K
Average Volume (3M)671.75K
Market Cap
$43.16M
Enterprise Value-$83.77M
Total Cash (Recent Filing)$131.54M
Total Debt (Recent Filing)$4.62M
Price to Earnings (P/E)―
Beta1.60
Next Earnings
Mar 04, 2025EPS Estimate
-$0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,082,948
10 Day Avg. Volume199,685
30 Day Avg. Volume671,754
Standard Deviation0.20
R-Squared0.10
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.31
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda2.35
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Achilles Therapeutics News
PremiumCompany Announcements
Achilles Therapeutics Explores Strategic Options Amid Financial Update
PremiumCompany Announcements
Achilles Therapeutics Shifts Strategy, Seeks Alternatives
PremiumCompany Announcements
Achilles Therapeutics Excels in Q2 with Promising Trials
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.05% Mutual Funds
― Other Institutional Investors
99.95% Public Companies and
Individual Investors
ACHL FAQ
What was Achilles Therapeutics’s price range in the past 12 months?
Achilles Therapeutics lowest stock price was $0.63 and its highest was $1.76 in the past 12 months.
What is Achilles Therapeutics’s market cap?
Currently, no data Available
When is Achilles Therapeutics’s upcoming earnings report date?
Achilles Therapeutics’s upcoming earnings report date is Mar 04, 2025 which is in 102 days.
How were Achilles Therapeutics’s earnings last quarter?
Achilles Therapeutics released its earnings results on Nov 14, 2024. The company reported -$0.48 earnings per share for the quarter, missing the consensus estimate of -$0.41 by -$0.07.
Is Achilles Therapeutics overvalued?
According to Wall Street analysts Achilles Therapeutics’s price is currently Overvalued.
Does Achilles Therapeutics pay dividends?
Achilles Therapeutics does not currently pay dividends.
What is Achilles Therapeutics’s EPS estimate?
Achilles Therapeutics’s EPS estimate is -$0.38.
How many shares outstanding does Achilles Therapeutics have?
Achilles Therapeutics has 41,087,902 shares outstanding.
What happened to Achilles Therapeutics’s price movement after its last earnings report?
Achilles Therapeutics reported an EPS of -$0.48 in its last earnings report, missing expectations of -$0.41. Following the earnings report the stock price went up 4.902%.
Which hedge fund is a major shareholder of Achilles Therapeutics?
Among the largest hedge funds holding Achilles Therapeutics’s share is Baker Bros Advisors LP. It holds Achilles Therapeutics’s shares valued at N/A.
---
Achilles Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.7%
Last 30 Days ▲ 8.7%
Last 30 Days ▲ 8.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
32.91%
12-Months-Change
Fundamentals
Return on Equity
-52.41%
Trailing 12-Months
Asset Growth
-30.03%
Trailing 12-Months
Company Description
Achilles Therapeutics
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
---
ACHL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ACHL
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-44.70%
reiterated a buy rating 8 months ago
Copying Geulah Livshits's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -44.70% per trade.
---